Combination antiretroviral (ARV) treatment has significantly increased survival in people diagnosed with AIDS-related illnesses of the brain,...

An international study comparing Norvir (ritonavir)-boosted Prezista (darunavir) to Kaletra (lopinavir/ritonavir) in people starting treatment...

The higher a person’s CD4 count upon starting HIV treatment, the higher their CD4 count will be 60 months later, say British researchers at th...

An experimental lower-strength tablet version of Kaletra (lopinavir plus ritonavir) is expected to work well in HIV-positive children

Slow but steady progress is being made on several HIV prevention fronts, say researchers in a special symposium on HIV prevention at the 11th...

A decade after beginning triple-drug therapy with very low CD4 counts, a majority of patients in Belgian PICASSO cohort study remain alive

Crestor is superior to Pravachol in HIV-positive people on antiretroviral therapy who experience LDL cholesterol and triglyceride elevations

Dr. Jose Ramos talks with Peter Staley about the unique challenges facing HIV-positive children and their health care providers.

Dr. José Gatell talks with David Evans about the latest treatment news on Selzentry and the continued interest in Kaletra monotherapy.

The experimental non-nucleoside reverse transcriptase inhibitor (NNRTI) rilpivirine is comparable to Sustiva in terms of reducing HIV levels a...